191 related articles for article (PubMed ID: 33239892)
1. Peripheral Blood Leukocyte N6-methyladenosine is a Noninvasive Biomarker for Non-small-cell Lung Carcinoma.
Pei Y; Lou X; Li K; Xu X; Guo Y; Xu D; Yang Z; Xu D; Cui W; Zhang D
Onco Targets Ther; 2020; 13():11913-11921. PubMed ID: 33239892
[TBL] [Abstract][Full Text] [Related]
2. Upregulated N6-Methyladenosine RNA in Peripheral Blood: Potential Diagnostic Biomarker for Breast Cancer.
Xiao H; Fan X; Zhang R; Wu G
Cancer Res Treat; 2021 Apr; 53(2):399-408. PubMed ID: 33138349
[TBL] [Abstract][Full Text] [Related]
3. Level of N6-Methyladenosine in Peripheral Blood RNA: A Novel Predictive Biomarker for Gastric Cancer.
Ge L; Zhang N; Chen Z; Song J; Wu Y; Li Z; Chen F; Wu J; Li D; Li J; Wang C; Wang H; Wang J
Clin Chem; 2020 Feb; 66(2):342-351. PubMed ID: 32040577
[TBL] [Abstract][Full Text] [Related]
4. Increased levels of N6-methyladenosine in peripheral blood RNA: a perspective diagnostic biomarker and therapeutic target for non-small cell lung cancer.
Yin H; Hong H; Yin P; Lu W; Niu S; Chen X; Xia Y; Jiang P; Huang Z
Clin Chem Lab Med; 2023 Feb; 61(3):473-484. PubMed ID: 36542027
[TBL] [Abstract][Full Text] [Related]
5. N6-Methyladenosine RNA Methylation Regulator-Related Alternative Splicing (AS) Gene Signature Predicts Non-Small Cell Lung Cancer Prognosis.
Zhao Z; Cai Q; Zhang P; He B; Peng X; Tu G; Peng W; Wang L; Yu F; Wang X
Front Mol Biosci; 2021; 8():657087. PubMed ID: 34179079
[TBL] [Abstract][Full Text] [Related]
6. Relationships of N6-Methyladenosine-Related Long Non-Coding RNAs With Tumor Immune Microenvironment and Clinical Prognosis in Lung Adenocarcinoma.
Zhao J; Lin X; Zhuang J; He F
Front Genet; 2021; 12():714697. PubMed ID: 34777460
[No Abstract] [Full Text] [Related]
7. N6-methyladenosine-regulated ADIRF impairs lung adenocarcinoma metastasis and serves as a potential prognostic biomarker.
Teng Y; Zhao X; Xi Y; Fu N
Cancer Biol Ther; 2023 Dec; 24(1):2249173. PubMed ID: 37700507
[TBL] [Abstract][Full Text] [Related]
8. An integrated model of
Zhang K; Han Z; Zhao H; Liu S; Zeng F
Ann Transl Med; 2021 Oct; 9(20):1523. PubMed ID: 34790729
[TBL] [Abstract][Full Text] [Related]
9. An N6-Methyladenosine-Related Gene Set Variation Score as a Prognostic Tool for Lung Adenocarcinoma.
Zhang H; Hu J; Liu A; Qu H; Jiang F; Wang C; Mo S; Sun P
Front Cell Dev Biol; 2021; 9():651575. PubMed ID: 34307344
[TBL] [Abstract][Full Text] [Related]
10. Retrospective study of gene signatures and prognostic value of m6A regulatory factor in non-small cell lung cancer using TCGA database and the verification of FTO.
Shi H; Zhao J; Han L; Xu M; Wang K; Shi J; Dong Z
Aging (Albany NY); 2020 Sep; 12(17):17022-17037. PubMed ID: 32903217
[TBL] [Abstract][Full Text] [Related]
11. Expressions of m6A RNA methylation regulators and their clinical predictive value in cervical squamous cell carcinoma and endometrial adenocarcinoma.
Wu H; Dong H; Fu Y; Tang Y; Dai M; Chen Y; Wang G; Wu Y
Clin Exp Pharmacol Physiol; 2021 Feb; 48(2):270-278. PubMed ID: 33006785
[TBL] [Abstract][Full Text] [Related]
12. High Expression of lncRNA HEIH is Helpful in the Diagnosis of Non-Small Cell Lung Cancer and Predicts Poor Prognosis.
He C; Huang D; Yang F; Huang D; Cao Y; Peng J; Luo X
Cancer Manag Res; 2022; 14():503-514. PubMed ID: 35173484
[TBL] [Abstract][Full Text] [Related]
13. LINC00628 is differentially expressed between lung adenocarcinoma and squamous cell carcinoma and is associated with the prognosis of NSCLC.
Liu T; Xu S; Liu X
Oncol Lett; 2022 Feb; 23(2):55. PubMed ID: 34992687
[TBL] [Abstract][Full Text] [Related]
14. Smoking-Induced M2-TAMs, via circEML4 in EVs, Promote the Progression of NSCLC through ALKBH5-Regulated m6A Modification of SOCS2 in NSCLC Cells.
Cheng C; Wang P; Yang Y; Du X; Xia H; Liu J; Lu L; Wu H; Liu Q
Adv Sci (Weinh); 2023 Aug; 10(22):e2300953. PubMed ID: 37246269
[TBL] [Abstract][Full Text] [Related]
15. Construction and validation of a novel prognostic model for lung squamous cell cancer based on N6-methyladenosine-related genes.
Jia E; Ren N; Guo B; Cui Z; Zhang B; Xue J
World J Surg Oncol; 2022 Feb; 20(1):59. PubMed ID: 35220962
[TBL] [Abstract][Full Text] [Related]
16. Identification of Prognostic Markers of N6-Methylandenosine-Related Noncoding RNAs in Non-Small-Cell Lung Cancer.
Zhang Z; Li J; Lu K; Wu W; Huang Z; Zhang C; Guo W; Li J; Lin L
J Oncol; 2022; 2022():3657349. PubMed ID: 35401751
[TBL] [Abstract][Full Text] [Related]
17. N6-Methyladenosine RNA modification in cerebrospinal fluid as a novel potential diagnostic biomarker for progressive multiple sclerosis.
Ye F; Wang T; Wu X; Liang J; Li J; Sheng W
J Transl Med; 2021 Jul; 19(1):316. PubMed ID: 34294105
[TBL] [Abstract][Full Text] [Related]
18. RNA m6A demethylase FTO-mediated epigenetic up-regulation of LINC00022 promotes tumorigenesis in esophageal squamous cell carcinoma.
Cui Y; Zhang C; Ma S; Li Z; Wang W; Li Y; Ma Y; Fang J; Wang Y; Cao W; Guan F
J Exp Clin Cancer Res; 2021 Sep; 40(1):294. PubMed ID: 34544449
[TBL] [Abstract][Full Text] [Related]
19. N6-Methyladenosine Regulators Promote Malignant Progression of Gastric Adenocarcinoma.
Zhao Y; Yan X; Wang Y; Zhou J; Yu Y
Front Oncol; 2021; 11():726018. PubMed ID: 35299934
[TBL] [Abstract][Full Text] [Related]
20. N6-Methyladenosine-Regulated mRNAs: Potential Prognostic Biomarkers for Patients With Lung Adenocarcinoma.
Sun J; Ping Y; Huang J; Zeng B; Ji P; Li D
Front Cell Dev Biol; 2021; 9():705962. PubMed ID: 34422827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
